Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESOLVE: Zunveyl in Mild to Moderate Alzheimer's Disease
NCT07633470Phase 4Recruiting
- Start
- May 2026
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
A Phase 4 trial of zavegepant in Alzheimer's disease (AD). Started May 2026; status: recruiting.
02
Drugs
zavegepant
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT07633470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07633470.